Amid growing support for the therapeutic use of psychedelics, the DEA has approved a clinical trial that uses MDMA to treat anxiety.
Renee Lewis has the story at Al Jazeera:
… Read the rest
The U.S. Drug Enforcement Administration (DEA) has approved the first clinical trial using MDMA along with psychotherapy to treat anxiety among people with life-threatening illnesses, researchers told Al Jazeera on Tuesday, adding that public support for the therapeutic use of psychedelic drugs is rapidly growing.
“The tide has changed for psychedelic research,” said Brad Burge, the communications director for the Multidisciplinary Association for Psychedelic Studies (MAPS), a California-based nonprofit research group that studies medicinal uses for psychedelics and marijuana and is sponsoring the study. The DEA approved the project on Friday, he said.
Unlike Ecstasy or Molly — names for MDMA sold on the street and often mixed with dangerous adulterants — pure MDMA has been proved “sufficiently safe” when taken a limited number of times in moderate doses, MAPS says on its website.